<DOC>
	<DOCNO>NCT01691248</DOCNO>
	<brief_summary>The objective study demonstrate efficacy safety Fidaxomicin versus placebo prophylaxis Clostridium difficile-Associated Diarrhea ( CDAD ) adult participant undergoing hematopoietic stem cell transplantation ( HSCT ) . The primary hypothesis Fidaxomicin superior placebo prevent CDAD participant undergo HSCT .</brief_summary>
	<brief_title>Safety Efficacy Fidaxomicin Versus Placebo Prophylaxis Against Clostridium Difficile-Associated Diarrhea Adults Undergoing Hematopoietic Stem Cell Transplantation ( MK-5119-001 )</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<criteria>Male female 18 year age old . Females childbearing potential must use adequate reliable method contraception ( e.g. , abstinence , barrier additional spermicide foam jelly , intrauterine device , hormonal contraception ) . Males female must agree avoid conception treatment four week follow end study treatment . Is undergo HSCT plan Fluoroquinolone prophylaxis . Informed consent provide . Ongoing active CDAD infection ( evidenced clinical sign diarrhea along presence either toxin A and/or B [ respective gene , tcdA and/or tcdB ] C. difficile stool ) current treatment CDAD . Undergoing cord blood transplant . Has fulminant colitis , toxic megacolon , ileus . A history inflammatory bowel disease ( ulcerative colitis Crohn 's disease ) . Women pregnant actively breast feeding ( woman childbearing potential must negative pregnancy test result prior dose study drug ) . Use drug potentially useful treatment CDAD ( e.g . oral Vancomycin , Metronidazole , oral Bacitracin , Fusidic Acid , Rifaximin , Nitazoxanide ) . Any condition , opinion investigator , would jeopardize safety right participant study , would make unlikely participant complete study , would confound result study . Participation clinical research study utilize investigational agent within one month prior screen study treatment period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Clostridium difficile</keyword>
	<keyword>Clostridium difficile-Associated Diarrhea</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>